The largest and longest study of the obesity drug Wegovy has shown people maintain significant weight loss for at least four ...
Users receiving weekly injections saw their weight fall, plateau, and stabilize over the course of a four-year trial—but it’s ...
A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight loss and improved health ...
The benefit-harm balance of initiating Glucagon-like Peptide-1 (GLP-1) receptor agonists (RAs) versus a placebo intervention.
STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new ...
The study found that the majority of people on Wegovy lost weight, on average 10% of their body weight, in the first 15 months of using the medication and sustained their weight loss over four years ...
As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly , increasing supplies, possible wider usage and ...
From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by ...
Patients taking semaglutide for a year saw significant improvements in exercise capacity and lost 2.9% more body weight ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.
The NHS will put 10,000 people a year on an 800-calorie-a-day “soup and shake” diet in a new national drive to help them ...